BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12118088)

  • 1. Photocoagulation-induced retinal gliosis is inhibited by systemically expressed soluble TGF-beta receptor type II via adenovirus mediated gene transfer.
    Hisatomi T; Sakamoto T; Yamanaka I; Sassa Y; Kubota T; Ueno H; Ohnishi Y; Ishibashi T
    Lab Invest; 2002 Jul; 82(7):863-70. PubMed ID: 12118088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of TGF-beta by in vivo gene transfer of a soluble TGF-beta type II receptor in the muscle inhibits corneal opacification, edema and angiogenesis.
    Sakamoto T; Ueno H; Sonoda K; Hisatomi T; Shimizu K; Ohashi H; Inomata H
    Gene Ther; 2000 Nov; 7(22):1915-24. PubMed ID: 11127579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of a soluble transforming growth factor beta type II receptor on the activation of rat hepatic stellate cells in primary culture.
    Cui X; Shimizu I; Lu G; Itonaga M; Inoue H; Shono M; Tamaki K; Fukuno H; Ueno H; Ito S
    J Hepatol; 2003 Nov; 39(5):731-7. PubMed ID: 14568254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of murine cranial suture patency mediated by a dominant negative transforming growth factor-beta receptor adenovirus.
    Song HM; Fong KD; Nacamuli RP; Warren SM; Fang TD; Mathy JA; Cowan CM; Aalami OO; Longaker MT
    Plast Reconstr Surg; 2004 May; 113(6):1685-97. PubMed ID: 15114130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene transfer of a soluble receptor of VEGF inhibits the growth of experimental eyelid malignant melanoma.
    Shiose S; Sakamoto T; Yoshikawa H; Hata Y; Kawano Y; Ishibashi T; Inomata H; Takayama K; Ueno H
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2395-403. PubMed ID: 10937546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catheter-based adenovirus-mediated local intravascular gene delivery of a soluble TGF-beta type II receptor using an infiltrator in porcine coronary arteries: efficacy and complications.
    Chung IM; Ueno H; Pak YK; Kim JW; Choi DH; Shin GJ; Yang WI; Jang Ys
    Exp Mol Med; 2002 Sep; 34(4):299-307. PubMed ID: 12515396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of renal glomerular disease using remote delivery of adenoviral-encoded solubletype II TGF-beta receptor fusion molecule.
    Haviv YS; Takayama K; Nagi PA; Tousson A; Cook W; Wang M; Lam JT; Naito S; Lei X; Carey DE; Curiel DT
    J Gene Med; 2003 Oct; 5(10):839-851. PubMed ID: 14533192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated transfer of a truncated transforming growth factor-beta (TGF-beta) type II receptor completely and specifically abolishes diverse signaling by TGF-beta in vascular wall cells in primary culture.
    Yamamoto H; Ueno H; Ooshima A; Takeshita A
    J Biol Chem; 1996 Jul; 271(27):16253-9. PubMed ID: 8663151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene transfer of soluble TGF-beta type II receptor inhibits experimental proliferative vitreoretinopathy.
    Oshima Y; Sakamoto T; Hisatomi T; Tsutsumi C; Ueno H; Ishibashi T
    Gene Ther; 2002 Sep; 9(18):1214-20. PubMed ID: 12215888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenoviral delivery of dominant-negative transforming growth factor beta type II receptor up-regulates transcriptional repressor SKI-like oncogene, decreases matrix metalloproteinase 2 in hepatic stellate cell and prevents liver fibrosis in rats.
    Marquez-Aguirre A; Sandoval-Rodriguez A; Gonzalez-Cuevas J; Bueno-Topete M; Navarro-Partida J; Arellano-Olivera I; Lucano-Landeros S; Armendariz-Borunda J
    J Gene Med; 2009 Mar; 11(3):207-19. PubMed ID: 19189315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus-mediated gene transfer of a secreted transforming growth factor-beta type II receptor inhibits luminal loss and constrictive remodeling after coronary angioplasty and enhances adventitial collagen deposition.
    Kingston PA; Sinha S; David A; Castro MG; Lowenstein PR; Heagerty AM
    Circulation; 2001 Nov; 104(21):2595-601. PubMed ID: 11714656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelium-specific adenoviral transfer of a dominant-negative mutant TGF-beta type II receptor stimulates embryonic lung branching morphogenesis in culture and potentiates EGF and PDGF-AA.
    Zhao J; Sime PJ; Bringas P; Gauldie J; Warburton D
    Mech Dev; 1998 Mar; 72(1-2):89-100. PubMed ID: 9533955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of an adenoviral vector encoding soluble transforming growth factor-beta type II receptor to the treatment of diabetic nephropathy in mice.
    Kondo T; Takemura G; Kosai K; Ohno T; Takahashi T; Esaki M; Goto K; Maruyama R; Murata I; Minatoguchi S; Fujiwara T; Fujiwara H
    Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1288-93. PubMed ID: 18505441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of radiation-induced pneumonitis by recombinant adenovirus-mediated transferring of soluble TGF-beta type II receptor gene.
    Haiping Z; Takayama K; Uchino J; Harada A; Adachi Y; Kura S; Caicun Z; Tsuzuki T; Nakanishi Y
    Cancer Gene Ther; 2006 Sep; 13(9):864-72. PubMed ID: 16710346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of TGF-β by catheter-based local intravascular gene delivery does not alter the in-stent neointimal response, but enhances inflammation in pig coronary arteries.
    Chung IM; Kim J; Pak YK; Jang Y; Yang WI; Han I; Park SJ; Park SW; Huh J; Wight TN; Ueno H
    Int J Cardiol; 2010 Dec; 145(3):468-75. PubMed ID: 20053468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated transmission of a dominant negative transforming growth factor-beta receptor inhibits in vitro mouse cranial suture fusion.
    Mehrara BJ; Spector JA; Greenwald JA; Ueno H; Longaker MT
    Plast Reconstr Surg; 2002 Aug; 110(2):506-14. PubMed ID: 12142669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Construction of recombinant adenovirus vector expressing extracellular domain of TbetaR-II-RANTES fusion gene and its anti-tumor effects].
    Wang XD; Liu H; Cao S; Li H; Ren XB; Hao XS
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):405-10. PubMed ID: 17974270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathologic amelioration of fibroproliferative change in rat irradiated lung using soluble transforming growth factor-beta (TGF-beta) receptor mediated by adenoviral vector.
    Nishioka A; Ogawa Y; Mima T; Jin YJ; Sonobe H; Kariya S; Kubota K; Yoshida S; Ueno H
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1235-41. PubMed ID: 15001268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of TGF-beta action ameliorates renal dysfunction and histologic progression in anti-GBM nephritis.
    Zhou A; Ueno H; Shimomura M; Tanaka R; Shirakawa T; Nakamura H; Matsuo M; Iijima K
    Kidney Int; 2003 Jul; 64(1):92-101. PubMed ID: 12787399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuated glial reactions and photoreceptor degeneration after retinal detachment in mice deficient in glial fibrillary acidic protein and vimentin.
    Nakazawa T; Takeda M; Lewis GP; Cho KS; Jiao J; Wilhelmsson U; Fisher SK; Pekny M; Chen DF; Miller JW
    Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2760-8. PubMed ID: 17525210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.